4DMedical Limited (FDMDF)
4DMedical Limited operates in the Medical - Devices industry of the Healthcare sector, headquartered in Carlton, VIC, AU. The stock last traded at $1.50, up 0.00% on the session, giving a market capitalisation of $903.5M. On trailing twelve-month figures it carries a trailing P/E of -5.48, a net margin of -2895.1%. Its beta of 1.97 implies it has historically moved more than the broad market.
Incorporated in 2012 and headquartered in Carlton, Australia, 4DMedical Limited operates as a medical technology enterprise across Australia and the United States. The company primarily focuses on bringing to market its innovative XV Technology, an advanced system for four-dimensional lung imaging. Beyond this core offering, its suite of products includes a software-as-a-service (SaaS) delivery model, specialized XV lung ventilation analysis software, and Permetium—a preclinical imaging system designed to quantify regional changes in pulmonary function. Additionally, the firm provides the AccuVent 200, a ventilator tailored for small animals.